Advances in Nervous System Disorders

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: 20 October 2024 | Viewed by 278

Special Issue Editors


E-Mail Website
Guest Editor
State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
Interests: neurodegeneration; epigenetics; regenerative medicine; mental disorders
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China
Interests: epigenetics; neurogenesis; neurodevelopment; regenerative medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue will highlight advances in the research of nervous system disorders, including stroke, trauma, headache, anxiety, depression, epilepsy, autism, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and tumor.

We will welcome critical reviews and high-quality original research articles dedicated to the advances in our understanding of cellular and molecular mechanisms of neurological diseases, and to diagnostic and therapeutic advances in nervous system disorders. The related topics include, but are not limited to, the following:

  • Cellular and molecular mechanisms of altered neurogenesis in brain disease;
  • Microglia in neuroinflammation and neurodegeneration;
  • Advances in brain organoid technologies and their applications;
  • Crosstalk between cancer cells and the nervous system;
  • Crosstalk between gut microbes and the nervous system;
  • Transcriptomic and epigenomic analysis of nervous system disorders;
  • Modeling nervous system disorders using human embryonic stem cells or induced pluripotent stem cells;
  • Deep brain stimulation for neurological and psychiatric disorders;
  • Diagnosing and screening nervous system disorders using artificial intelligence techniques;
  • Gene therapy for nervous system disorders.

We look forward to reading your contributions.

Prof. Dr. Zhao-Qian Teng
Prof. Dr. Changmei Liu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurological disease
  • psychiatric disorder
  • neurodegeneration
  • brain tumor
  • neuroinflammation
  • neurogenesis
  • gut microbes
  • gene therapy
  • deep brain stimulation
  • modeling neurological disorders
  • diagnosis and screening

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 1198 KiB  
Review
PIWI-Interacting RNAs: A Pivotal Regulator in Neurological Development and Disease
by Xian Pan, Wang Dai, Zhenzhen Wang, Siqi Li, Tao Sun and Nan Miao
Genes 2024, 15(6), 653; https://doi.org/10.3390/genes15060653 - 21 May 2024
Viewed by 165
Abstract
PIWI-interacting RNAs (piRNAs), a class of small non-coding RNAs (sncRNAs) with 24–32 nucleotides (nt), were initially identified in the reproductive system. Unlike microRNAs (miRNAs) or small interfering RNAs (siRNAs), piRNAs normally guide P-element-induced wimpy testis protein (PIWI) families to slice extensively complementary transposon [...] Read more.
PIWI-interacting RNAs (piRNAs), a class of small non-coding RNAs (sncRNAs) with 24–32 nucleotides (nt), were initially identified in the reproductive system. Unlike microRNAs (miRNAs) or small interfering RNAs (siRNAs), piRNAs normally guide P-element-induced wimpy testis protein (PIWI) families to slice extensively complementary transposon transcripts without the seed pairing. Numerous studies have shown that piRNAs are abundantly expressed in the brain, and many of them are aberrantly regulated in central neural system (CNS) disorders. However, the role of piRNAs in the related developmental and pathological processes is unclear. The elucidation of piRNAs/PIWI would greatly improve the understanding of CNS development and ultimately lead to novel strategies to treat neural diseases. In this review, we summarized the relevant structure, properties, and databases of piRNAs and their functional roles in neural development and degenerative disorders. We hope that future studies of these piRNAs will facilitate the development of RNA-based therapeutics for CNS disorders. Full article
(This article belongs to the Special Issue Advances in Nervous System Disorders)
Show Figures

Figure 1

Back to TopTop